AN2 Therapeutics, Inc.
Funding reported, $40M, last update 5 months ago
Pharma biotech · Headquarters United States
Everything we hold on AN2 Therapeutics, Inc., newest first. Every line links to the filing or report it came from.
- 2026-03-25Headcount Not Stated Growing and expanding
AN2 Therapeutics, Inc. raised $40M in a private placement
AN2 Therapeutics, Inc. reported a $40M private placement to the SEC on 2026-03-25, listing an address in CA. The filing records the money only; it names no roles and no hiring plan.
- 2026-03-20Pay Change Leadership moves
AN2 Therapeutics, Inc. 8-K filing (Item 5.02): officer or director change
AN2 Therapeutics adjusts stock option terms for executives and board members in Menlo Park, affecting compensation structure.
- 2026-01-29Headcount Not Stated Leadership moves
AN2 Therapeutics, Inc. 8-K filing (Item 5.02): officer or director change
AN2 Therapeutics appoints a new Vice President of Controller and Principal Accounting Officer in Menlo Park, with no immediate change to headcount.
AN2 Therapeutics, Inc.. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Aug 20, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/an2-therapeutics/ Licensed CC BY 4.0; every record links to the document behind it.The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker